ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

A randomized, Double-blind, Placebo and Active controlled, Multicenter, Phase 3 Study to Access the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely Active Rheumatoid Arthritis who Are Naive to MTX Therapy

Implementing Organization

All India Institute of Medical Sciences
Principal Investigator
Dr Uma Kumar
Professor & Head
|
All India Institute of Medical Sciences

Abstract

NA

Patents

NA

Achievements

NA

Outcome / Output

NA

Publications

NA

Related Research

View All
Funding Organization
Funding Organization
Gilead Sciences, Inc., USA
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Orthopedics
Start Year
2018
End Year
2022
Sanction Amount
₹ 10.00 L
Status
Completed
Contact
umaakumar@yahoo.co.in
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
NA
No. of Patents
Filed : 00
Grant : 00
Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
arrowtop
Latest Updates
Loading…
Recently added across the portal